TONGLING JIEYA BIOLOGIC TECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.21 CNY | +0.29% |
|
-2.86% | -21.22% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 720M 99.45M | Sales 2025 * | 825M 114M | Capitalization | 2.21B 305M |
|---|---|---|---|---|---|
| Net income 2024 * | 134M 18.51M | Net income 2025 * | 157M 21.69M | EV / Sales 2024 * | 3.07 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.68 x |
| P/E ratio 2024 * |
16.4
x | P/E ratio 2025 * |
-
| Employees | 683 |
| Yield 2024 * |
1.54% | Yield 2025 * |
1.8% | Free-Float | 28.37% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.29% | ||
| 1 week | -2.86% | ||
| Current month | +0.11% | ||
| 1 month | +6.21% | ||
| 3 months | -1.59% | ||
| 6 months | -24.90% | ||
| Current year | -21.22% |
1 week
26.75
27.88
1 month
25.5232.59
Current year
23.1435.58
1 year
23.1439.30
3 years
23.1497.58
5 years
23.1497.58
10 years
23.1497.58
| Managers | Title | Age | Since |
|---|---|---|---|
Ying Chuan Cai
CEO | Chief Executive Officer | 54 | 99-08-30 |
Yun Feng Lu
CHM | Chairman | 41 | 18-07-31 |
Xian Guo Yuan
ADM | Chief Administrative Officer | 55 | 04-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yun Feng Lu
CHM | Chairman | 41 | 18-07-31 |
Ying Chuan Cai
CEO | Chief Executive Officer | 54 | 99-08-30 |
Yan Feng
BRD | Director/Board Member | 50 | 99-07-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.09% | 12 M€ | -16.71% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-21 | 27.21 | +0.29% | 373 760 |
| 24-05-21 | 27.13 | -1.81% | 732,433 |
| 24-05-20 | 27.63 | -0.14% | 570,620 |
| 24-05-17 | 27.67 | +0.11% | 499,413 |
| 24-05-16 | 27.64 | +0.58% | 583,300 |
End-of-day quote Shenzhen S.E., May 21, 2024
More quotes
Tongling Jieya Biologic Technology Co Ltd is a China-based company mainly engaged in the production of wipes. The Company's main businesses are the research and development, production and sales of sanitary products. The Company's wet wipes products include baby series, adult functional series, antibacterial disinfection series, household cleaning series, medical care series and pet cleaning series. The Company is also engaged in the production of facial masks.
Sector
Personal Products
Calendar
2024-08-22
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
27.21
CNY
Average target price
35
CNY
Spread / Average Target
+28.63%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -21.22% | 304M | |
| +9.91% | 45.03B | |
| -4.35% | 18.4B | |
| -6.20% | 4.09B | |
| +3.08% | 3.62B | |
| +7.06% | 2.66B | |
| -16.70% | 1.55B | |
| +56.07% | 1.42B | |
| +15.61% | 1B | |
| +19.66% | 816M |
- Stock Market
- Equities
- 301108 Stock